Origin & tradition
Not traditional: ALA was identified as a mitochondrial cofactor in the 1950s.
Western tradition · Mitochondrial Cofactor
A mitochondrial cofactor active in both fat and water — the only antioxidant that regenerates glutathione, vitamin C, and vitamin E simultaneously.
↑ iHerb link is an affiliate link — we may earn a commission at no cost to you.
Not traditional: ALA was identified as a mitochondrial cofactor in the 1950s.
Key active: R-Alpha-lipoic acid (mitochondrial cofactor & universal antioxidant).
ALA is a co-factor for α-keto acid dehydrogenase complexes in mitochondria and a free-radical scavenger that regenerates glutathione, ascorbate, and tocopherols. R-ALA (natural form) shows greater mitochondrial uptake. Human RCTs focus on diabetic neuropathy (FDA-approved in Germany), metabolic syndrome, and cognitive aging.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| Insulin sensitivity / blood glucose | Increases | Moderate | B |
| Diabetic peripheral neuropathy | Decreases | Strong | A |
| Antioxidant markers | Increases | Moderate | B |
| Body weight (modest) | Decreases | Minor | C |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
R-ALA (R-alpha lipoic acid) is the natural isomer; racemic (RS-ALA) is 50/50 mix. R-ALA has better bioavailability and potency at lower doses. Stabilized R-ALA (Na-RALA or Bio-Enhanced R-ALA) has better shelf life.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Human RCTs in diabetic neuropathy and metabolic endpoints; aging-specific trials emerging
ALA is a co-factor for α-keto acid dehydrogenase complexes in mitochondria and a free-radical scavenger that regenerates glutathione, ascorbate, and tocopherols. R-ALA (natural form) shows greater mitochondrial uptake. Human RCTs focus on diabetic neuropathy (FDA-approved in Germany), metabolic syndrome, and cognitive aging.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-12. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Compare the evidence
The mitochondrial electron carrier that declines with age and statin use — with cardiovascular trial support.
A gut-derived metabolite that triggers mitophagy — with human trials on muscle and mitochondrial function.
The most potent known NRF2 activator, from broccoli, with human trials in cancer chemoprevention and neuroprotection.
The dark chocolate flavonoid linked to myostatin inhibition, cardiovascular protection, and mitochondrial biogenesis in human trials.
Suppliers
Tell us what you need and we will source suppliers for you.